Hereditary angioedema due to C1 inhibitor deficiency: real-world experience from the Icatibant Outcome Survey in Spain

BACKGROUND: The Icatibant Outcome Survey (IOS) is an international registry monitoring the use of icatibant, a bradykinin B(2) receptor antagonist indicated for the acute treatment of hereditary angioedema (HAE) attacks. Our goal was to assess disease characteristics and icatibant treatment outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Guilarte, Mar, Sala-Cunill, Anna, Baeza, María Luisa, Cabañas, Rosario, Hernández, María Dolores, Ibañez, Ethel, de Larramendi, Carlos Hernando, Lleonart, Ramon, Lobera, Teófilo, Marqués, Luis, de San Pedro, Blanca Sáenz, Botha, Jaco, Andresen, Irmgard, Caballero, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715569/
https://www.ncbi.nlm.nih.gov/pubmed/34965883
http://dx.doi.org/10.1186/s13223-021-00641-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715569/
https://www.ncbi.nlm.nih.gov/pubmed/34965883
http://dx.doi.org/10.1186/s13223-021-00641-3

Ejemplares similares